Advertisement

Headache

  • Nailyn Rasool
Chapter

Abstract

Headache is one of the most common conditions for which adults seek medical attention. According to the World Health Organization, approximately 50% of the adult population globally has experienced a headache at least once over the past year, and it is one of the highest causes worldwide for disability. Patients frequently assume that their headaches are of ophthalmic origin, and this is usually not correct. The majority of headaches do not have an ocular etiology, but certainly this must be ruled out, particularly in patients who have persistent unexplained eye or orbital pain, those who are certain that their discomfort is related to visual activities, and those with associated complaints, such as weight loss, visual changes, jaw claudication, or vertigo.

Keywords

Migraine Tension-type headache Trigeminal autonomic cephalalgias Headache International Classification of Headache Disorders Giant cell arteritis 

Suggested Reading

  1. Bendtsen L, Jensen R. Tension-Type Headache. Neurol Clin. 2009;27(2):525–35.CrossRefGoogle Scholar
  2. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1–211.Google Scholar
  3. Rizzoli P, Mullally WJ. Headache. Am J Med. 2018;131(1):17–24.CrossRefGoogle Scholar
  4. Jay GW, Barkin RL. Primary headache disorders part I- migraine and the trigeminal autonomic cephalalgias. Dis Mon. 2017;63(11):308–38.CrossRefGoogle Scholar
  5. Bruce BB, Biousse V, Newman NJ. Update on idiopathic intracranial hypertension. Am J Ophthalmol. 2011;152(2):163–9.CrossRefGoogle Scholar
  6. Puledda F, Messina R, Goadsby PJ. An update on migraine: current understanding and future directions. J Neurol. 2017;264(9):2031–9.CrossRefGoogle Scholar
  7. Newman LC. Trigeminal autonomic cephalalgias. CONTINUUM: Lifelong Learning in Neurology. 21:1041–57.Google Scholar
  8. Stone JH, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D, Brouwer E, Cid MC, Dasgupta B, Rech J, Salvarani C, Schett G, Schulze-Koops H, Spiera R, Unizony SH, Collinson N. Trial of tocilizumab in giant-cell arteritis. N Engl J Med. 2017;377(4):317–28.CrossRefGoogle Scholar
  9. Solomon CG, Weyand CM, Goronzy JJ. Giant-cell arteritis and polymyalgia rheumatica. N Engl J Med. 2014;371(1):50–7.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Nailyn Rasool
    • 1
  1. 1.Department of OphthalmologyUniversity of California, San FranciscoSan FranciscoUSA

Personalised recommendations